Please assess the completion status of the following clinical trial:

Trial Title: Alterations of Immunologic Mediators During Severe Sepsis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* age \>= 18 y~* agreement with study procedures~* 3 of 4 SIRS-criteria~* proven or highly suspected infection~* 2 or more sepsis-induced organ failures~* start of first sepsis-induced organ failure within the last 36 hours~Exclusion Criteria:~* non-agreement with study procedures~* signs of severe sepsis with organ failure \> 36 hours~* chronic immuno-compromising diseases~* chronic therapy with anti-inflammatory drugs~* non-curable cancer~* chronic renal failure with hemodialysis~* pregnancy or breast-feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).